Evidence map›Paper›PMID 30843084›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2019

Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia.

Laurence Duplomb, Julie Rivière, Gaëtan Jego, Romain Da Costa, Arlette Hammann, Jessica Racine, Alain Schmitt, Nathalie Droin, Claude Capron, Marie-Anne Gougerot-Pocidalo and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 2 countries.

Laurence DuplombInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France. laurence.duplomb@chu-dijon.fr.ORCID 0000-0002-5715-3759
Julie RivièreInserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France.
Gaëtan JegoInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Romain Da CostaInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Arlette HammannInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Jessica RacineLaboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France.
Alain SchmittInserm, U1016, Institut Cochin, F-75679, Paris, France.
Nathalie DroinInserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France.
Claude CapronInserm, U1016, Institut Cochin, F-75679, Paris, France.
Marie-Anne Gougerot-PocidaloInserm U1149-Centre de Recherche sur l'Inflammation, Université Paris Diderot, F-75890, Paris, France.
Laurence DubrezInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Bernard AralInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Arnaud LafonLaboratoire d'odontologie, CHU Dijon, F-21000, Dijon, France.
Patrick EderyService de génétique clinique, Hôpital Femme Mère Enfant, CHU Lyon, HCL, F-69000, Lyon, France.
Jamal GhoumidCentre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Nord, Hôpital Jeanne de Flandres, CHRU Lille, F-59037, Lille, France.
Edward BlairDepartment of Clinical Genetics, Oxford Regional Genetics Service, The Churchill Hospital, Oxford, OX3 9DU, UK.
Salima El Chehadeh-DjebbarService de génétique médicale, CHU Strasbourg, F-67000, Strasbourg, France.
Virginie CarmignacInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Julien ThevenonInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Julien GuyLaboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France.
François GirodonLaboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France.
Jean-Noël BastieInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Laurent DelvaInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Laurence FaivreInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Christel Thauvin-RobinetInserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
Eric SolaryInserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France.
Inserm · FRCHU Dijon Bourgogne · FRDélégation Paris 5 · FRChurchill Hospital · GBHôpital Femme Mère Enfant · FRHôpital Jeanne de Flandre · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cohen syndrome (CS) is a rare genetic disorder due to mutations in VPS13B gene. Among various clinical and biological features, CS patients suffer from inconsistent neutropenia, which is associated with recurrent but minor infections. We demonstrate here that this neutropenia results from an exaggerate rate of neutrophil apoptosis. Besides this increased cell death, which occurs in the absence of any endoplasmic reticulum stress or defect in neutrophil elastase (ELANE) expression or localization, all neutrophil functions appeared to be normal. We showed a disorganization of the Golgi apparatus in CS neutrophils precursors, that correlates with an altered glycosylation of ICAM-1 in these cells, as evidenced by a migration shift of the protein. Furthermore, a striking decrease in the expression of SERPINB1 gene, which encodes a critical component of neutrophil survival, was detected in CS neutrophils. These abnormalities may account for the excessive apoptosis of neutrophils leading to neutropenia in CS. KEY MESSAGES: Cohen syndrome patients' neutrophils display normal morphology and functions. Cohen syndrome patients' neutrophils have an increased rate of spontaneous apoptosis compared to healthy donors' neutrophils. No ER stress or defective ELA2 expression or glycosylation was observed in Cohen syndrome patients' neutrophils. SerpinB1 expression is significantly decreased in Cohen syndrome neutrophils as well as in VPS13B-deficient cells.

Indexed as

ApoptosisAdolescentAdultChildChild, PreschoolDevelopmental DisabilitiesDown-RegulationFemaleFingersHumansIntellectual DisabilityMaleMicrocephalyMiddle AgedMuscle HypotoniaMutationSERPINB1 protein, humanSerpinsApoptosisCohen syndromeNeutropeniaSerpin B1

Identifiers

PMID30843084
OpenAlexW2921488877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.